Stop use of 10 fluids, including ringer’s lactate infusion, state asks govt hospitals

Kolkata:  The state Health department on Saturday issued an order asking all government hospitals to stop using 10 fluids, including ringer’s lactate infusion, for the safety of patients in the wake of the death of a 21-year-old woman who gave birth to a child at Midnapore Medical College and died at the hospital on Friday after allegedly being administered “expired” saline.

On instructions of CM Mamata Banerjee, who also heads the Health department, Chief Secretary Manoj Pant has sought a detailed report on the incident from the Principal Secretary, Health, by Sunday night.

The detailed list of the fluids have been circulated among all health establishments in the state.Meanwhile, the 13-member team that has been constituted by the Health department to probe the incident visited Midnapore Medical College on Saturday and sought individual written opinions from the doctors on the incident.

The team also spoke with three of the four patients, who were administered the same saline at the hospital and subsequently fell ill. Members could not speak to one of them, Nasreen Khatun, as her condition is extremely critical and has been put on ventilator support since Friday.

“The treatment that is presently being offered to these four patients is going in the right direction,” said a member of the committee.

The 13-member committee later held a meeting at Midnapore circuit house with the District Magistrate and Chief Medical Officer (CMO) in the presence of other concerned officials. According to sources in the Health department, the committee will also probe whether the incident happened due to the negligence of any doctor/doctors in the hospital.

The ringer’s lactate saline supplied by a Siliguri-based pharma company has come under the scanner of the Health department following the incident. The state Drug Control on December 10 had blacklisted the company. “It will be examined whether the infusion administered was procured after the blacklisting or it was in stock earlier. If it was in stock, it should have been exhausted,” a Health department official said.

Related Posts

  • Pharma
  • February 17, 2025
  • 70 views
GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals Ltd…

  • Pharma
  • February 17, 2025
  • 66 views
Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Shares of Glenmark Pharmaceuticals Ltd rose 4% on February 17 after the firm gave a strong guidance for FY26 and it returned to black in the December quarter. The drugmaker…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wow! What a Change of Heart in Practitioners of Allopathy!

Wow! What a Change of Heart in Practitioners of Allopathy!

GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gain 20% following strong Q3FY25 results

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

US Tariffs on pharma: What are the potential impact on Indian drugmakers

US Tariffs on pharma: What are the potential impact on Indian drugmakers

Twin Health bats a1000 before enters Digital Health NY 100

Twin Health bats a1000 before enters Digital Health NY 100

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%